Pasar al contenido principal

INTERVENCIONES MULTIMODALES EN NEUROESTIMULACION PARA CARACTERIZAR EL FUNCIONAMIENTO CEREBRAL Y LOS RESULTADOS CLINICOS ASOCIADOS A LA ENFERMEDAD DE PARKINSON

PID2021-124427OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE CADIZ

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Significance of neurodegeneration and neuroplasticity serum biomarkers in Parkinson’s disease patients treated with subthalamic stimulation

  • Sanmartino Balog, Florencia Soledad
  • Cano-Cano, Fátima
  • Rashid Abdu Rahim López, Raúl
  • Lozano Soto, Elena María
  • Macias García, Paloma
  • Sánchez Fernández, Francisco Luis
  • López Sosa, Fernando
  • Gómez Jaramillo, María Laura
  • Riqué-Dormido, Jesús
  • Escamilla-Sevilla, Francisco
  • Espinosa-Rosso, Raúl
  • González Rosa, Javier Jesús
This work was supported by i) the Spanish Ministry of Science, Innovation and Universities (MICIU) under grants PID2021-124427OB-I00 and CNS2023-143743 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU and NextGenerationEU/PRTR and ii) under grant PI-0034-2019 funded by the Andalusian Ministry of Health and Families and by the ERDF/EU. FC-C and PM-G were supported by the INiBICA and the University of Cadiz through predoctoral fellowships (INiBICA and UCA PIF programs), respectively. AJC-G was supported by the University of Cadiz through a postdoctoral fellowship (\u201CPlan CIE Estabiliza\u201D Program). We thank the patients and their families for their participation.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Neuroimaging and serum biomarkers of neurodegeneration and neuroplasticity in Parkinson’s disease patients treated by intermittent theta-burst stimulation over the bilateral primary motor area: a randomized, double-blind, sham-controlled, crossover trial study

  • Rashid Abdu Rahim López, Raúl
  • Macias García, Paloma
  • Sánchez Fernández, Francisco Luis
  • Cano Cano, Fátima
  • Sarrias-Arrabal, E.
  • Sanmartino Balog, Florencia Soledad
  • Méndez Bertolo, Constantino José
  • Lozano Soto, Elena María
  • Gutiérrez-Cortés, R.
  • González Moraleda, Álvaro Antonio
  • Forero, L.
  • López Sosa, Fernando
  • Zuazo Ojeda, Mirem Amaya
  • Gómez Molinero, Rocío
  • Gómez Ramírez, Jaime D.
  • Paz Expósito, José
  • Rubio-Esteban, G.
  • Espinosa-Rosso, R
  • Cruz Gómez, Álvaro Javier
  • González Rosa, Javier Jesús
Background and objectives: Intermittent theta-burst stimulation (iTBS) is a patterned form of excitatory transcranial magnetic stimulation that has yielded encouraging results as an adjunctive therapeutic option to alleviate the emergence of clinical deficits in Parkinson’s disease (PD) patients. Although it has been demonstrated that iTBS influences dopamine-dependent corticostriatal plasticity, little research has examined the neurobiological mechanisms underlying iTBS-induced clinical enhancement. Here, our primary goal is to verify whether iTBS bilaterally delivered over the primary motor cortex (M1) is effective as an add-on treatment at reducing scores for both motor functional impairment and nonmotor symptoms in PD. We hypothesize that these clinical improvements following bilateral M1-iTBS could be driven by endogenous dopamine release, which may rebalance cortical excitability and restore compensatory striatal volume changes, resulting in increased striato-cortico-cerebellar functional connectivity and positively impacting neuroglia and neuroplasticity. Methods: A total of 24 PD patients will be assessed in a randomized, double-blind, sham-controlled crossover study involving the application of iTBS over the bilateral M1 (M1 iTBS). Patients on medication will be randomly assigned to receive real iTBS or control (sham) stimulation and will undergo 5 consecutive sessions (5 days) of iTBS over the bilateral M1 separated by a 3-month washout period. Motor evaluation will be performed at different follow-up visits along with a comprehensive neurocognitive assessment; evaluation of M1 excitability; combined structural magnetic resonance imaging (MRI), resting-state electroencephalography and functional MRI; and serum biomarker quantification of neuroaxonal damage, astrocytic reactivity, and neural plasticity prior to and after iTBS. Discussion: The findings of this study will help to clarify the efficiency of M1 iTBS for the treatment of PD and further provide specific neurobiological insights into improvements in motor and nonmotor symptoms in these patients. This novel project aims to yield more detailed structural and functional brain evaluations than previous studies while using a noninvasive approach, with the potential to identify prognostic neuroprotective biomarkers and elucidate the structural and functional mechanisms of M1 iTBS-induced plasticity in the cortico-basal ganglia circuitry. Our approach may significantly optimize neuromodulation paradigms to ensure state-of-the-art and scalable rehabilitative treatment to alleviate motor and nonmotor symptoms of PD., 17 páginas.